Hong Kong's Market Slips Amid Surprising HSBC Loss
Hong Kong's stock market declined due to HSBC's unexpected $400 million loss linked to a UK fraud case. Despite the downturn, a new IPO boom emerged with Star Sports Medicine debuting 120% higher. Meanwhile, CATL's shares led gains with their sodium-ion battery deal, amid subdued trading due to regional holidays.
On Tuesday, Hong Kong's stock market saw a decline following an unexpected financial setback at HSBC. The banking giant reported a $400 million loan loss tied to a fraud case in the UK, leading to a 5.2% fall in its shares. The benchmark Hang Seng Index closed 0.76% lower at 25,889.61.
Despite the downturn, new IPOs showcased potential, with Star Sports Medicine's stock making an impressive debut, climbing nearly 120% above its offering price. The China-based medical device company raised HK$827.4 million ($105.62 million), reflecting strong market demand.
Elsewhere in the market, battery maker Contemporary Amperex Technology led gains with a 3.7% rise, following news of a novel sodium-ion battery deal. However, broader trading volumes remained light due to holidays in Japan and South Korea, while the offshore yuan held steady amidst regional currency struggles.
(With inputs from agencies.)

